THE NITRIC OXIDE DONATOR NAPROXCINOD HAS BLOOD PRESSURE EFFECTS SIMILAR TO PLACEBO IN PATIENTS ON RENIN-ANGIOTENSIN SYSTEM BLOCKERS: 9D.02
W WHITE(University of Connecticut), M. Weber(University of Zurich), J Dijian, Hayet Frayssinet, Brigitte Duquesroix, Thomas J. Schnitzer
Cited by 3
Related Papers
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
|New England Journal of Medicine|2000|4k
Clopidogrel with or without Omeprazole in Coronary Artery Disease
|New England Journal of Medicine|2010|1.2k
Towards a mechanism-based approach to pain management in osteoarthritis
|Nature Reviews Rheumatology|2013|304
A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
|Arthritis & Rheumatology|2019|209
Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study
|Clinical Infectious Diseases|2024|41